Filing Details

Accession Number:
0001415889-23-011251
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-18 21:59:29
Reporting Period:
2023-07-14
Accepted Time:
2023-07-18 21:59:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705850 E Joseph Gilliam C/O Glaukos Corporation
One Glaukos Way
Aliso Viejo CA 92656
President & Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-07-14 19,599 $41.69 140,083 No 4 M Direct
Common Stock Acquisiton 2023-07-14 10,000 $30.92 150,083 No 4 M Direct
Common Stock Acquisiton 2023-07-14 10,000 $39.10 160,083 No 4 M Direct
Common Stock Acquisiton 2023-07-14 2,500 $39.10 162,583 No 4 M Direct
Common Stock Disposition 2023-07-14 42,099 $78.34 120,484 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-07-14 19,599 $0.00 19,599 $41.69
Common Stock Stock Option (Right to Buy) Disposition 2023-07-14 10,000 $0.00 10,000 $30.92
Common Stock Stock Option (Right to Buy) Disposition 2023-07-14 10,000 $0.00 10,000 $39.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
117,044 2027-05-05 No 4 M Direct
18,437 2028-03-14 No 4 M Direct
40,466 2030-03-12 No 4 M Direct
Footnotes
  1. Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  2. This trade was made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
  3. This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
  4. This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
  5. This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.